Related Experiment Video
Updated: May 14, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Breast cancer. Individualized therapy concepts].
1Brustzentrum, Frauenklinik Großhadern, Universität München, Marchioninistr. 15, 81377, München. nadia.harbeck@med.uni-muenchen.de
Der Internist
|February 2, 2013
Summary
Personalized medicine tailors breast cancer treatment using molecular subtypes and markers to avoid over or under-treatment. New targeted therapies are advancing care for early and advanced stages, improving outcomes.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Context:
- Personalized medicine is crucial for breast cancer treatment planning.
- Molecular subtypes (luminal A, B, basal-like) guide adjuvant therapy decisions.
- Prognostic and predictive markers (hormone receptors, HER2, Ki-67, uPA/PAI-1, Oncotype DX®) prevent undertreatment or overtreatment.
Purpose:
- To explore the evolving landscape of personalized medicine in breast cancer.
- To highlight the role of molecular information and targeted therapies in treatment strategies.
- To discuss the increasing complexity and future directions of breast cancer therapy.
Summary:
- Individualized therapy concepts are central to breast cancer management.
- Molecular profiling enables tailored adjuvant systemic therapy for early-stage disease.
- Targeted therapies augment or may replace standard chemotherapy and endocrine therapy in both early and advanced breast cancer.
- Therapeutic regimens are becoming more complex, integrating molecular data and novel agents.
Impact:
- Personalized approaches aim to optimize treatment efficacy and minimize side effects.
- Future studies will validate these complex regimens, ensuring appropriate use of adjuvant chemotherapy.
- Targeted therapies offer hope for improved survival and managing advanced breast cancer as a chronic condition.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...